4D Molecular Therapeutics (FDMT) Current Deferred Revenue (2019 - 2026)
4D Molecular Therapeutics' Current Deferred Revenue was $360,000 in Q2 2026, down 66.2% from $1.07 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Current Deferred Revenue (2019 - 2026) Analysis & Trends
From Q4 2019 onward, 4D Molecular Therapeutics has reported Current Deferred Revenue for 22 quarters.
- Current Deferred Revenue shows a five-year compound annual growth rate of -44.1% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $257,000 in FY2024 (-5.9%), $273,000 in FY2023 (-69.1%), $884,000 in FY2022 (-66.0%) and $2.6 million in FY2021 (-60.5%).
- Quarterly Current Deferred Revenue has moved between $35,000 (Q3 2024) and $2.6 million (Q4 2021) over five years.
- Compared with a year earlier, Current Deferred Revenue was higher in two of the last six quarters, with growth averaging 127.5%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q3 2025 (growth of 928.6%); the worst was Q3 2023 (a decline of 94.1%).
- Per Business Quant data, FDMT's Current Deferred Revenue in the three quarters before Q2 2026 was $360,000 (Q1 2026), $360,000 (Q4 2025) and $360,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 360,000.00 |
| Mar 31, 2026 | 360,000.00 |
| Dec 31, 2025 | 360,000.00 |
| Sep 30, 2025 | 360,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 866,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Dec 31, 2023 | 273,000.00 |
| Sep 30, 2023 | 130,000.00 |
| Jun 30, 2023 | 576,000.00 |
| Mar 31, 2023 | 778,000.00 |
| Dec 31, 2022 | 884,000.00 |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 2.26 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 1.73 Mn |
| Jun 30, 2021 | 3.02 Mn |
| Mar 31, 2021 | 7.09 Mn |
API Access
4D Molecular Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();